Founded Year

2014

Stage

Series E | Alive

Total Raised

$524.8M

Valuation

$0000 

Last Raised

$123M | 8 mos ago

Revenue

$0000 

Mosaic Score
The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.

+86 points in the past 30 days

About Insilico Medicine

Insilico Medicine focuses on artificial intelligence in drug discovery and development. The company provides artificial intelligence platforms for multi-omics target discovery, deep biology analysis, automated drug design, and predicting outcomes in clinical trials. The technologies are intended to assist in the process of discovering and developing new medications for various diseases. It was founded in 2014 and is based in New Territories, Hong Kong.

Headquarters Location

Phase 2, Hong Kong Science Park, Pak Shek Kok Unit 310, 3rd Floor, Building 8W

New Territories,

Hong Kong

Loading...

Insilico Medicine's Product Videos

ESPs containing Insilico Medicine

The ESP matrix leverages data and analyst insight to identify and rank leading companies in a given technology landscape.

EXECUTION STRENGTH ➡MARKET STRENGTH ➡LEADERHIGHFLIEROUTPERFORMERCHALLENGER
Healthcare & Life Sciences / Drug R&D Tech

The AI-derived small molecule drugs market leverages AI and machine learning to discover and develop novel small molecule therapeutics. Companies in this market combine physics-based AI algorithms, deep learning models, and generative AI with experimental validation to enable target identification, virtual screening, and lead optimization. Proprietary platforms integrate computational approaches w…

Insilico Medicine named as Leader among 15 other companies, including Recursion Pharmaceuticals, Schrodinger, and Atomwise.

Insilico Medicine's Products & Differentiators

    Pharma.AI

    Global’s first end-to-end generative Al software and robotics platform designed to improve the quality and productivity of pharmaceutical research, currently commercially-available

Loading...

Research containing Insilico Medicine

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Insilico Medicine in 20 CB Insights research briefs, most recently on Aug 22, 2025.

Expert Collections containing Insilico Medicine

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Insilico Medicine is included in 7 Expert Collections, including AI 100 (All Winners 2018-2025).

A

AI 100 (All Winners 2018-2025)

199 items

Winners of CB Insights' annual AI 100, a list of the 100 most promising AI startups in the world.

A

Artificial Intelligence

12,998 items

Companies developing artificial intelligence solutions, including cross-industry applications, industry-specific products, and AI infrastructure solutions.

D

Digital Health 50

150 items

The winners of the second annual CB Insights Digital Health 150.

D

Digital Health

11,440 items

The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.

D

Drug Discovery Tech Market Map

221 items

This CB Insights Tech Market Map highlights 220 drug discovery companies that are addressing 12 distinct technology priorities that pharmaceutical companies face.

G

Generative AI

2,826 items

Companies working on generative AI applications and infrastructure.

Insilico Medicine Patents

Insilico Medicine has filed 71 patents.

The 3 most popular patent topics include:

  • transcription factors
  • proteins
  • clusters of differentiation
patents chart

Application Date

Grant Date

Title

Related Topics

Status

7/6/2023

2/18/2025

Trifluoromethyl compounds, Transcription factors, Designer drugs, Prodrugs, Cannabinoids

Grant

Application Date

7/6/2023

Grant Date

2/18/2025

Title

Related Topics

Trifluoromethyl compounds, Transcription factors, Designer drugs, Prodrugs, Cannabinoids

Status

Grant

Latest Insilico Medicine News

Laboratory Robotics Market Projected to Witness a Growth of US $4.24 Billion by 2029 | The Business Research Company

Sep 12, 2025

It will grow to $4.24 billion in 2029 at a compound annual growth rate (CAGR) of 9.7%. ” — The Business Research Company LONDON, GREATER LONDON, UNITED KINGDOM, September 12, 2025 / EINPresswire.com / -- "Get 30% Off All Global Market Reports With Code ONLINE30 – Stay Ahead Of Trade Shifts, Macroeconomic Trends, And Industry Disruptors Laboratory Robotics Market Growth Forecast: What To Expect By 2025? There has been a swift expansion in the market size of laboratory robotics in recent years. The market size is projected to rise from $2.67 billion in 2024 to $2.93 billion in 2025, demonstrating a Compound Annual Growth Rate (CAGR) of 10.0%. The notable growth during the historic phase can be credited to factors such as the escalating demand for high-throughput screening, the pressing need to minimize human error, the expansion of pharmaceutical and biotech research, the lack of skilled laboratory workforce, and an increasing emphasis on improving lab efficiency and productivity. There is a positive growth forecast for the laboratory robotics market size in the upcoming years. It is predicted to reach $4.24 billion in 2029, with a compound annual growth rate (CAGR) of 9.7%. The expansion during the forecast period can be linked to factors such as a growing need for customized medicine, wider acceptance of cloud-based laboratory software, heightened focus on laboratory data integrity, broadening of drug discovery pipelines, and a surge in the requirement for laboratory efficiency and throughput. Key trends to watch during this forecast period encompass the use of artificial intelligence in lab robotics, incorporation of digital twins with real-time analytics, the creation of modular and adaptable robotic systems, management of labs via the cloud, and the usage of cooperative robots (cobots). Download a free sample of the laboratory robotics market report: https://www.thebusinessresearchcompany.com/sample.aspx?id=27324&type=smp What Are Key Factors Driving The Demand In The Global Laboratory Robotics Market? The laboratory robotics market is predicted to progress owing to the surge in research and clinical trials. These trials and research endeavors are methodical probes into the innovation, evaluation, and validation of the effectiveness, safety, and best usage of new medicinal technologies, drugs, and therapies on humans. The escalating occurrence of chronic and complex diseases necessitates the need for better and new treatments, hence increasing clinical trials and research. Laboratory robotics bolsters these trials and research by automating menial tasks, promoting efficiency, and curbing human errors. They fast-track experimental workflows, warranting accuracy in data and backing high-throughput screening, and thus advancing the speed and quality of scientific innovations. For instance, the Association of the British Pharmaceutical Industry (ABPI), reported in November 2023 that the total count of industry-initiated clinical trials hit 411 in 2022, marking a 4.3% rise from 394 trials in 2021. As such, the upswing in research and clinical trials is propelling the laboratory robotics market's growth. Who Are The Leading Players In The Laboratory Robotics Market? Major players in the Laboratory Robotics Global Market Report 2025 include: • Siemens Healthineers AG • F. Hoffmann-La Roche Ltd • Thermo Fisher Scientific Inc. • ABB Ltd • Becton, Dickinson and Company • Kawasaki Heavy Industries Ltd. • Agilent Technologies Inc. • Sartorius AG • Festo AG & Co. KG • Yaskawa Electric Corporation What Are The Key Trends Shaping The Laboratory Robotics Industry? Key businesses within the laboratory robotics sector are channeling their efforts into creating cutting-edge technologies, examples of which include bipedal humanoid robotic lab assistants. These developments are aimed at augmenting automation, securing accuracy, and boosting productivity within lab processes. This category of robots, with their human-like two-legged design, have the ability to undertake lab tasks which usually demand human agility and action. For example, Insilico Medicine, an American biotech firm, introduced a bipedal humanoid robot to their 100% robotic AI-based drug discovery laboratory in March 2025. Developed to handle equipment usually operational by humans, this robot aids in autonomy by involving itself in essential tasks such as data collection, experiment monitoring, reagent management, and overseeing the lab. The ambition is to establish a research facility that is genuinely self-sufficient, where AI and robotics work together efficiently, therefore minimizing human input in everyday but essential lab activities. This innovation signifies a substantial step towards entirely autonomous drug discovery. Hence,with these humanoid robots, both the pharmaceutical and the wider scientific research will see enhanced operational efficiency and the facilitation of advanced workflows. Analysis Of Major Segments Driving The Laboratory Robotics Market Growth The laboratory robotics market covered in this report is segmented 1) By Component: Hardware, Software, Services 2) By Product Type: Automated Liquid Handling Robots, Automated Plate Handlers, Robotic Arms, Lab Automation Workstations, Microplate Readers And Washers 3) By Application: Drug Discovery, Clinical Diagnosis, Microbiology Solutions, Genomics Solutions, Proteomics Solutions 4) By End User: Clinical Laboratory, Research Laboratory Subsegments: 1) By Hardware: Robotic Arms, Automated Liquid Handlers, Microplate Movers, Sample Storage Systems, Sensors And Cameras, Lab-On-A-Chip Devices, Pipetting Robots, Workstations 2) By Software: Workflow Management Software, Data Analysis And Visualization Tools, Robotic Control Software, Laboratory Information Management Systems (LIMS), Scheduling Software, Integration And Interface Software 3) By Services: Installation And Commissioning, Maintenance And Repair, Calibration Services, Training And Support, Software Upgrades And System Integration, Validation And Compliance Services View the full laboratory robotics market report: https://www.thebusinessresearchcompany.com/report/laboratory-robotics-global-market-report Which Region Is Expected To Lead The Laboratory Robotics Market By 2025? The Laboratory Robotics Global Market Report 2025 identified North America as the leading region for the year 2024. It projects Asia-Pacific as the region with the highest anticipated growth rate for the predicted period. The report encompasses regions such as North America, Asia-Pacific, Western Europe, Eastern Europe, South America, the Middle East, and Africa. Browse Through More Reports Similar to the Global Laboratory Robotics Market 2025, By The Business Research Company Printing Machinery And Equipment Global Market Report 2025 https://www.thebusinessresearchcompany.com/report/printing-machinery-and-equipment-global-market-report Equipment Finance Service Global Market Report 2025 https://www.thebusinessresearchcompany.com/report/equipment-finance-service-global-market-report Equipment Leasing Software Global Market Report 2025 https://www.thebusinessresearchcompany.com/report/equipment-leasing-software-global-market-report Speak With Our Expert: Saumya Sahay Americas +1 310-496-7795 Asia +44 7882 955267 & +91 8897263534 Europe +44 7882 955267 Email: saumyas@tbrc.info The Business Research Company - www.thebusinessresearchcompany.com Follow Us On: • LinkedIn: https://in.linkedin.com/company/the-business-research-company Oliver Guirdham The Business Research Company info@tbrc.info Visit us on social media: LinkedIn Facebook X Legal Disclaimer: EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Insilico Medicine Frequently Asked Questions (FAQ)

  • When was Insilico Medicine founded?

    Insilico Medicine was founded in 2014.

  • Where is Insilico Medicine's headquarters?

    Insilico Medicine's headquarters is located at Phase 2, Hong Kong Science Park, Pak Shek Kok, New Territories.

  • What is Insilico Medicine's latest funding round?

    Insilico Medicine's latest funding round is Series E.

  • How much did Insilico Medicine raise?

    Insilico Medicine raised a total of $524.8M.

  • Who are the investors of Insilico Medicine?

    Investors of Insilico Medicine include Warburg Pincus, Prosperity7 Ventures, OrbiMed, Eli Lilly and Company, Pudong VC and 38 more.

  • Who are Insilico Medicine's competitors?

    Competitors of Insilico Medicine include METiS Technologies, AIBODY, InSilicoTrials, Aqemia, Isomorphic Laboratories and 7 more.

  • What products does Insilico Medicine offer?

    Insilico Medicine's products include Pharma.AI and 1 more.

  • Who are Insilico Medicine's customers?

    Customers of Insilico Medicine include Exelixis, Stemline Therapeutics , Sanofi and Tenacia.

Loading...

Compare Insilico Medicine to Competitors

Atomwise Logo
Atomwise

Atomwise develops machine learning-based discovery engines and uses artificial intelligence (AI)-based neural networks to help discover new medicines. It predicts drug candidates for pharmaceutical companies, start-ups, and research institutions and designs drugs using computational drug design. It was formerly known as Chematria. The company was founded in 2012 and is based in San Francisco, California.

Insitro Logo
Insitro

Insitro is a data-driven drug discovery and development company that utilizes machine learning and high-throughput biology. The company has a machine learning platform that combines in vitro cellular data with human clinical data to identify insights and interventions in metabolism, oncology, and neuroscience. Insitro's approach uses technology to model disease states and design therapeutic interventions. It was founded in 2018 and is based in South San Francisco, California.

S
SOM Biotech

SOM Biotech operates as a clinical-stage drug discovery and development company that focuses on the treatment of rare Central Nervous System disorders. The company utilizes an artificial intelligence platform to discover and develop drugs, with emphasis on orphan diseases and repurposing existing drugs for new therapeutic indications. SOM Biotech's lead product has completed Phase 2b trials for Huntington's Disease. It was founded in 2009 and is based in Barcelona, Spain.

Aqemia Logo
Aqemia

Aqemia focuses on transforming the drug discovery process. The company offers technology that combines quantum-inspired physics and machine learning to scale the drug discovery process, generating a rapidly growing pipeline of new drug candidates. It primarily sells to the pharmaceutical industry. It was founded in 2019 and is based in Paris, France.

ProclaimRx Logo
ProclaimRx

ProclaimRx operates in the biopharmaceutical sector and provides AI-driven solutions for sales and marketing teams. It focuses on workflows that support healthcare professional interactions. ProclaimRx serves the biopharmaceutical industry and uses its knowledge in health tech platforms and AI to offer decision support and sales force solutions. It was founded in 2023 and is based in New York, New York.

Cradle Logo
Cradle

Cradle focuses on protein engineering in the biotechnology sector, using machine learning to optimize protein sequences. It provides tools for designing improved variants of target proteins, integrating laboratory data, and predicting performance to support research and development. Its solutions are relevant for biotech teams working on various applications, including therapeutics, enzymes, vaccines, peptides, and antibodies. It was founded in 2021 and is based in Amsterdam, Netherlands.

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.